"Phenylbutyrates" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivatives of 4-phenylbutyric acid, including its salts and esters.
| Descriptor ID |
D010654
|
| MeSH Number(s) |
D02.241.223.651
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Phenylbutyrates".
Below are MeSH descriptors whose meaning is more specific than "Phenylbutyrates".
This graph shows the total number of publications written about "Phenylbutyrates" by people in this website by year, and whether "Phenylbutyrates" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phenylbutyrates" by people in Profiles.
-
Phenylbutyrate modulates polyamine acetylase and ameliorates Snyder-Robinson syndrome in a Drosophila model and patient cells. JCI Insight. 2022 07 08; 7(13).
-
Chemical chaperone treatment improves levels and distributions of connexins in Cx50D47A mouse lenses. Exp Eye Res. 2018 10; 175:192-198.
-
Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia. Mol Cancer Ther. 2014 Aug; 13(8):1979-90.
-
Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy. Hepatology. 2014 Mar; 59(3):1073-83.
-
The chemical chaperones tauroursodeoxycholic and 4-phenylbutyric acid accelerate thyroid hormone activation and energy expenditure. FEBS Lett. 2011 Feb 04; 585(3):539-44.
-
Loss of function and impaired degradation of a cataract-associated mutant connexin50. Eur J Cell Biol. 2003 May; 82(5):209-21.
-
Activation of the cardiac ATP-sensitive K+ channel by ER-001533, a newly synthesized vasorelaxant. Circ Res. 1992 May; 70(5):1054-61.
-
The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg. 1990 Mar; 102(3):219-24.